Lipocine Inc diskutieren
Lipocine Inc.
WKN: A3EBZD / Symbol: LPCN / Name: Lipocine / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /
3,67 €
-
Buy Lipocine Inc
Buy Lipocine Inc
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for LPCN provided by MarketBeat
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for LPCN provided by MarketBeat
Neueste Beiträge
B__Riley in Matthews International Corp. diskutieren